Evidence map›Paper›PMID 21775659›Full record

ArticleInvestigative ophthalmology & visual science2011

Downregulation of glutamine synthetase via GLAST suppression induces retinal axonal swelling in a rat ex vivo hydrostatic pressure model.

Makoto Ishikawa, Takeshi Yoshitomi, Charles F Zorumski, Yukitoshi Izumi

Open access · greenAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A lab-on-a-chip model of glaucoma.Brain and behavior · 2020
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Experimentally Induced Mammalian Models of Glaucoma.BioMed research international · 2015
    Review
  20. Neurosteroids are endogenous neuroprotectants in an ex vivo glaucoma model.Investigative ophthalmology & visual science · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Makoto IshikawaDepartment of Ophthalmology, Akita University School of Medicine, Japan. mako@med.akita-u.ac.jp
Takeshi Yoshitomi
Charles F Zorumski
Yukitoshi Izumi
Akita University · JPWashington University in St. Louis · US

Funding

Washington University Center for Translational NeuroscienceP30NS057105 · NINDS · WASHINGTON UNIVERSITY · PI HOLTZMAN, DAVID M. · 2006 to 2011
$8.7M
MODULATION OF HIPPOCAMPAL SYNAPTIC PLASTICITYR01MH077791 · NIMH · WASHINGTON UNIVERSITY · PI ZORUMSKI, CHARLES F · 2007 to 2013
$2.4M
NIMH NIH HHS MH077791NIMH NIH HHS R01 MH077791NINDS NIH HHS P30 NS057105
6 · The paper itself

Abstract

PURPOSE. High levels of glutamate can be toxic to retinal GCs. Thus, effective buffering of extracellular glutamate is important in preserving retinal structure and function. GLAST, a major glutamate transporter in the retina, and glutamine synthetase (GS) regulate extracellular glutamate accumulation and prevent excitotoxicity. This study was an examination of changes in function and expression of GLAST and GS in ex vivo rat retinas exposed to acute increases in ambient pressure. METHODS. Ex vivo rat retinas were exposed to elevated hydrostatic pressure for 24 hours. The expression of GLAST and GS were examined using immunochemistry and real-time PCR analysis. Also examined were the effects of (2S,3S)-3-[3-[4-(trifluoromethyl) benzoylamino] benzyloxy] aspartate (TFB-TBOA), an inhibitor of glutamate transporters, and l-methionine-S-sulfoximine (MSO), an inhibitor of GS. RESULTS. In this acute model, Western blot and real-time RT-PCR analyses revealed that substantially (75 mm Hg), but not moderately (35 mm Hg), elevated pressure depressed GLAST expression, diminished GS activity, and induced axonal swelling between the GC layer and the inner limiting membrane. However, at the moderately elevated pressure (35 mm Hg), administration of either TFB-TBOA or MSO also induced axonal swelling and excitotoxic neuronal damage. MSO did not depress GLAST expression but TFB-TBOA significantly suppressed GS, suggesting that downregulation of GS during pressure loading may result from impaired GLAST expression. CONCLUSIONS. The retina is at risk during acute intraocular pressure elevation due to downregulation of GS activity resulting from depressed GLAST expression.

Indexed as

Disease Models, AnimalAnimalsAspartic AcidAxonsBlotting, WesternDown-RegulationExcitatory Amino Acid Transporter 1Fluorescent Antibody Technique, IndirectGlutamate-Ammonia LigaseGlutamic AcidHydrostatic PressureMaleMethionine SulfoximineRatsRats, Sprague-DawleyRetinal Degeneration(2S,3S)-3-(3-(4-(trifluoromethyl)benzoylamino)benzyloxy)aspartateAspartic AcidExcitatory Amino Acid Transporter 1Glutamate-Ammonia LigaseGlutamic AcidMethionine SulfoximineRNA, MessengerSlc1a3 protein, rat

Identifiers

PMID21775659
PMCPMC3175999
OpenAlexW2111632005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.